Trial intelligence / Profile preview

Prophylactic amoxicillin/clavulanate after bronchoscopy in patients with bronchial stenosis

jRCTs061240111Recruiting

Start
Jan 2025
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of amoxicillin + clavulanate in Airways Infection (2 arms). Primary endpoint: Respiratory infection requiring antibiotic treatment within 4 weeks. Started Jan 2025; status: recruiting.

02

Drugs

amoxicillin + clavulanate
03

Conditions

Airways Infection

Beyond the preview

Go deeper on jRCTs061240111.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs061240111.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call